Tag Archives: Long Term

Top Long Term Companies To Invest In Right Now

ISIS recruiting on teen social networks Twitter has significantly ramped up its anti-ISIS efforts by shutting down thousands of terrorists’ accounts and adding staff to monitor terrorist activity on its network.

The social media company said in a blog post Friday that it has suspended 125,000 accounts over the past seven months for threatening or promoting terrorist acts. Most of the people behind the accounts were affiliated with or supported ISIS, Twitter said.

ISIS recruiters have successfully used Twitter to lure disillusioned people to join their cause.

“We condemn the use of Twitter to promote terrorism,” the company said in the blog post. “As the nature of the terrorist threat has changed, so has our ongoing work in this area.”

Top Long Term Companies To Invest In Right Now: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors’ Opinion:

  • [By Michael Flannelly]

    At Bank of America Merrill Lynch’s Global Healthcare Conference on Friday, Amgen, Inc.’s (AMGN) Investor Relations VP Arvind Sood suggested that the biotech company could boost its dividend meaningfully through 2015.

    Sood believes that the company will be able to deliver significant EPS growth over the next two years. This is partially due to Amgen’s deal to acquire Onyxx Pharmaceuticals, which should be accretive to adjusted profit growth. As such, Sood said he sees Amgen boosting its dividend over that time frame, with a payout ratio of 75% to 80%. For more on payout ratios, see The Truth About Dividend Payout Ratio.

    By 2017, Sood believes that Amgen will hit global sales of $41 billion.

    Amgen shares were up 54 cents, or 0.48%, during pre-market trading on Friday. The stock is up 31.62% year-to-date.

  • [By Bioassociate Consulting]

    Focused on development and commercialization of products for the aesthetic medicine market, Kythera is led by a highly experienced management team, boasting impressive record in the pharmaceutical industry and the aesthetic medicine market, as former Allergan (AGN) and Amgen (AMGN) executives. Kythera has been flying under the radar since its October 2012 IPO, and the successful completion of the Phase III program is expected to bring KYTH to the front, and in our opinion, makes it a buyout target.

Top Long Term Companies To Invest In Right Now: CVR Partners LP(UAN)

CVR Partners, LP engages in the production of nitrogen fertilizers including ammonia and urea ammonium nitrate. The company was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP operates as a subsidiary of CVR Energy, Inc.

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Going forward I will be looking to add investments on my watchlist and trim other positions. It will be interesting to see how an overweight commodity portfolio will perform relative to the rest of the market.

     Cost Basis# SharesCurrent Price% of PortfolioCurrent ValueReturnMetal/Miners      Sprott Physical Gold Trust (PHYS)$12.4985$11.043.75%$938.40-13.13%Sprott Physical Silver Trust (PSLV)$7.95125$8.744.37%$1,092.509.04%FreePort-McMoran (FCX)$31.6731$33.874.20%$1,049.976.50%Ishares MSCI Global Gold Miners ETF (RING)$13.0695$10.644.04%$1,010.80-22.74%Energy      Statoil ASA(STO)$21.7940$22.683.63%$907.203.92%Vanguard Natural Resources LLC (VNR)$27.5636$27.874.01%$1,003.321.11%ConocoPhillips (COP)$63.6822.43$71.006.37%$1,592.5310.31%Agriculture      CVR Partner LP (UAN)$26.3630.9$18.932.34%$584.94-39.25%Adecoagro$6.78125$7.443.72%$930.008.87%Archer-Daniels Midland (ADM)$34.80 30$37.244.47%$1,117.206.55%Mixed Commodity      Powershares DB Commodity Index (DBC)$26.3540$25.954.15%$1,038.00-1.54%Sprott Resource Corp$3.34400$2.714.34%$1,084.00-23.25%    Total % of portfolio49.40%               Cost Basis12,666.00      Current Value12,348.86      Return-2.50%  Source: Investing For The Future Surge In Commodity Prices

    Disclosure: I am long ADM, FCX, UAN, AGRO, RING, VNR, SCPZF.PK, COP, DBC, PHYS, PSLV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

  • [By Robert Rapier]

    Enter CVR Partners LP (NYSE: UAN), the only company in the US to produce fertilizer from petroleum coke (petcoke). Petcoke is a byproduct of petroleum refining, and prices are usually set off coal prices, since these two products compete in the same niche. Thus the same dynamics that currently threaten the distributions of Rentech Nitrogen Partners and Terra Nitrogen Company play in CVR Partners’ favor.

Top Promising Stocks To Buy Right Now: ConocoPhillips(COP)

ConocoPhillips operates as an integrated energy company worldwide. The company?s Exploration and Production (E&P) segment explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids. Its Midstream segment gathers, processes, and markets natural gas; and fractionates and markets natural gas liquids in the United States and Trinidad. The company?s Refining and Marketing (R&M) segment purchases, refines, markets, and transports crude oil and petroleum products, such as gasolines, distillates, and aviation fuels. Its Chemicals segment manufactures and markets petrochemicals and plastics. This segment offers olefins and polyolefins, including ethylene, propylene, and other olefin products; aromatics products, such as benzene, styrene, paraxylene, and cyclohexane, as well as polystyrene and styrene-butadiene copolymers; and various specialty chemical products comprising organosulfur chemicals, solvents, catalyst s, drilling chemicals, mining chemicals, and engineering plastics and compounds. The company?s Emerging Businesses segment develops new technologies and businesses. It focuses on power generation; and technologies related to conventional and nonconventional hydrocarbon recovery, refining, alternative energy, biofuels, and the environment. This segment also offers E-Gas, a gasification technology producing high-value synthetic gas. ConocoPhillips was founded in 1917 and is based in Houston, Texas.

Advisors’ Opinion:

  • [By Lisa Levin]

    ConocoPhillips (NYSE: COP) reported weaker-than-expected results for its fourth quarter.

    ConocoPhillips said that it lost $0.90 per share in the fourth quarter on revenue of $6.77 billion. Wall Street analysts were expecting the company to lose $0.52 per share on revenue of $9.08 billion.

  • [By Ben Levisohn]

    Unlike ConocoPhillips (COP), Hess’s (HES) dividend wasn’t big enough to move the needle if cut. So it’s selling stock instead:

    Bloomberg News

    Hess has priced the concurrent offering of ~28.8mm shares of common stock and ~11.5mm depositary shares, assuming the over-allotment options are exercised. The depositary shares represent a 1/20th interest in each share of Hess 8% Mandatory Convertible Preferred Stock, which unless converted earlier at the option of the holder will convert on or around February 1st, 2019 into Hess common shares. Based on the equity offering price of $39/share, we estimate total net proceeds of ~$1.65bn net common offering proceeds of $1.09bn and net depositary share offering proceeds of ~$558mm. The offerings represent ~10% of Hess prior outstanding share count and ~15% on fully diluted basis including the conversion of the convertible preferred shares.

    Hess said it will use the proceeds from the offerings for general corporate purposes and to strengthen its balance sheet. Prior to the offering, Hess already had one of the strongest balance sheets within our E&P coverage group with a net debt/capitalization ratio of ~14% at YE15 and more than ~$2.7bn of cash on its balance sheet. However, based on current NYMEX strip prices and after dividends, Hess was confronting a ~$2.0bn cash flow outspend this year and another ~$2.3bn in 2017. Mgmt. emphasized that it has no intention to cut the companys dividend.

    Mgmt. emphasized that the offerings were not intended to pre-fund any M&A activity or to accelerate drilling activity.

    Shares of Hess have tumbled 11% to $38.89 at 1:26 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has fallen 2.2% to $56.

Top Long Term Companies To Invest In Right Now: Rhino Resource Partners LP(RNO)

Rhino Resource Partners LP produces, processes, and sells coal of various steam and metallurgical grades in the United States. The company holds interests in various surface and underground coal mines located in Central Appalachia, Northern Appalachia, the Illinois Basin, and the Western Bituminous region. As of December 31, 2010, it operated 10 mines, including 5 underground and 5 surface mines located in Kentucky, Ohio, and West Virginia. The company markets its steam coal primarily to electric utility companies as fuel for their steam-powered generators; and metallurgical coal for steel and coke producers. It also engages in mining limestone from reserves located at its Sands Hill mining complex and sells it as aggregate to various construction companies and road builders. The company was founded in 2003 and is based in Lexington, Kentucky.

Advisors’ Opinion:

  • [By Alexis Xydias]

    Investors are regaining confidence, squeezing pessimists who say the economy remains sluggish outside of Germany and point to record-low trading volume as a lack of conviction in the Euro Stoxxs 61 percent rally of the past two years. Besides gains in stocks from Banco Bilbao Vizcaya Argentaria SA to Renault SA (RNO), yields on Spanish and Italian bonds have declined to a two-year low compared with German bunds and the euro has strengthened 4.6 percent to $1.35 in the past six months.

Top Long Term Companies To Invest In Right Now: Protective Life Corporation(PL)

Protective Life Corporation and its subsidiaries engage in the production, distribution, and administration of insurance and investment products in the United States. Its Life Marketing segment markets universal life, variable universal life, level premium term insurance, and bank-owned life insurance products primarily through a network of independent insurance agents and brokers, stockbrokers, and independent marketing organizations. The company?s Acquisitions segment focuses on acquiring, converting, and servicing life insurance policies and annuity products sold to individuals, which are acquired from other companies. Its Annuities segment markets variable annuity products that offer the policyholder the opportunity to invest in various investment accounts; and fixed annuity products, such as modified guaranteed annuities, single premium deferred annuities, single premium immediate annuities, and equity indexed annuities primarily through broker-dealers, financial ins titutions, and independent agents and brokers. The company?s Stable Value Products segment offers guaranteed funding agreements to special purpose entities; fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, institutional investors, bank trust departments, and money market funds; and guaranteed investment contracts to qualified retirement savings plans. Its Asset Protection segment primarily markets extended service contracts, and credit life and disability insurance to protect consumers? investments in automobiles, watercraft, and recreational vehicles; and markets a guaranteed asset protection product primarily through a national network of approximately 3,750 automobile, marine, and recreational vehicle dealers. The company was founded in 1907 and is headquartered in Birmingham, Alabama.

Advisors’ Opinion:

  • [By David Sterman]

    My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).

Top Long Term Companies For 2016

Getty Images You’ve probably been seeing headlines about yet another financial crash on the horizon. It’s true, the International Monetary Fund has released grim projections for the immediate future of world finance. Why? Well, it’s complicated. Basically, the forces which were put in place to fix the last recession may just have caused another bubble in another sector. The 2008 Recession The last bubble and subsequent recession were caused when Wall Street took on huge amounts of cheap debt. This debt, as it was repaid, was meant to pay off many times over. But the reality of the situation was much different. In many cases, the debt was put on the back of private individuals who couldn’t handle it, who shouldn’t have been offered a loan in the first place. They defaulted en masse and — among many other factors — it caused the bubble to pop. Debt is only worth something if it gets paid back, plus interest. In 2008 the whole house of cards collapsed. Massive firms like Lehman Brothers went under and a lot of money just disappeared. The ‘Brittle’ 2015 Global Market Things are different this time around and Wall Street isn’t on the hook. In an attempt to stabilize global markets following the last recession, borrowing has been made extremely cheap in developed economies like the United States. Economists thought this would shock the heartbeat of the pre-Crash economy back to life, but the U.S. was never able to wean borrowers off of ultra low rates. Investors of all sizes have been snapping up this cheap debt for several years now, causing many to worry that these are exactly the same conditions that caused the 2008 crash. There are other global factors which make this scenario different from that of 2008. This time, Wall Street isn’t the one holding all of this cheap debt. This time it’s spread all around the world, in companies, private investors and world governments. Many of the nations involved are so-called “developing” economies, which have been using cheap borrowing to fund expansion. What Does This Mean for You?

Top Long Term Companies For 2016: CytRx Corporation(CYTR)

CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. Its drug development pipeline includes INNO-206, which is in Phase II clinical trials for the treatment of soft tissue sarcomas and is in Phase Ib/2 clinical trials for the treatment of solid tumors; and tamibarotene that is in Phase II clinical trials for the treatment of non-small-cell lung cancer and acute promyelocytic leukemia. The company also develops Bafetinib, which is in Phase II clinical trials for the treatment of B-cell chronic lymphocytic leukemia and advanced prostate cancer, as well as in pharmacokinetic clinical trial for brain cancer. CytRx Corporation was founded in 1985 and is headquartered in Los Angeles, California.

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Long Term Companies For 2016: Rhino Resource Partners LP(RNO)

Rhino Resource Partners LP produces, processes, and sells coal of various steam and metallurgical grades in the United States. The company holds interests in various surface and underground coal mines located in Central Appalachia, Northern Appalachia, the Illinois Basin, and the Western Bituminous region. As of December 31, 2010, it operated 10 mines, including 5 underground and 5 surface mines located in Kentucky, Ohio, and West Virginia. The company markets its steam coal primarily to electric utility companies as fuel for their steam-powered generators; and metallurgical coal for steel and coke producers. It also engages in mining limestone from reserves located at its Sands Hill mining complex and sells it as aggregate to various construction companies and road builders. The company was founded in 2003 and is based in Lexington, Kentucky.

Advisors’ Opinion:

  • [By Alexis Xydias]

    Investors are regaining confidence, squeezing pessimists who say the economy remains sluggish outside of Germany and point to record-low trading volume as a lack of conviction in the Euro Stoxxs 61 percent rally of the past two years. Besides gains in stocks from Banco Bilbao Vizcaya Argentaria SA to Renault SA (RNO), yields on Spanish and Italian bonds have declined to a two-year low compared with German bunds and the euro has strengthened 4.6 percent to $1.35 in the past six months.

Top Prefered Companies To Invest In Right Now: Avanir Pharmaceuticals Inc(AVNR)

Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. The company primarily offers NUEDEXTA, a unique proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect. Its product line also comprises AVP-923 in Phase II clinical trial for the treatment of central neuropathic pain in patients with multiple sclerosis; and in Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain. In addition, the company provides Docosanol 10% cream, an over-the-counter product for cold sores treatment. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California.

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analysts upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

Top Long Term Companies For 2016: Brown(n)

N Brown Group plc operates as an Internet and catalogue home shopping company in the United Kingdom. The company principally offers womenswear, menswear, footwear, household, and electrical products, as well as provides insurance services. It also operates in the Republic of Ireland, Germany, and the United States. The company was founded in 1859 and is based in Manchester, the United Kingdom.

Advisors’ Opinion:

  • [By Alex Jordon]

    He already owns a good chunk of NetSuite (N), whose revenue grew 35% last quarter, beating earnings estimates by $0.03 a share. Ellison’s been profiting from the cloud while dismissing its significance. With the Salesforce agreement his company is, too. (Fool)

Top Long Term Companies For 2016: Leucadia National Corporation(LUK)

Leucadia National Corporation, through its subsidiaries, engages in manufacturing, land based contract oil and gas drilling, gaming entertainment, real estate, medical product development, and winery operations in the United States and internationally. Its manufacturing operations include remanufacturing, manufacturing, and/or distribution dimension lumber, home center boards for retailers, pine decking, and other specialty wood products; and manufacturing and marketing lightweight plastic netting used in building and construction, erosion control, packaging, agricultural, carpet padding, filtration, and consumer products. The company?s land based contract oil and gas drilling operations include the provision of drilling services to independent oil and natural gas exploration and production companies in the Mid-Continent region of the United States, including Oklahoma, Texas, Arkansas, Louisiana, and Kansas. As of December 31, 2010, it had 38 drilling rigs. The company?s g aming entertainment operations consist of owning the Hard Rock Hotel & Casino Biloxi located in Biloxi, Mississippi, which consists of 325 rooms and suites, 1,268 slot machines, 52 table games, 6 live poker tables, 5 restaurants, and spa. Its real estate activities include investment in commercial properties, residential land development projects, and other unimproved land. The company?s medical product development operations comprise the development of MP4OX that has completed a phase II proof of concept clinical trial and is a solution of cell-free hemoglobin, administered intravenously to provide oxygen delivery to oxygen deprived tissues. In addition, Leucadia National Corporation engages in the production and sale of wines; and investment and evaluation of gasification projects to convert various types of low grade fossil fuels into energy products. The company was founded in 1854 and is based in New York, New York.

Advisors’ Opinion:

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.